Fen Wang

Employment

Employment history is unavailable.

Education

• Southern Medical University Doctor of Medicine
  2019 - Present
• Peking University Mater of Medicine
  2009 - 2011
• Tongji Medical College Bachelor of Medicine
  1996 - 2001

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• 20 Years of Breakthroughs: Transforming the Fight Against Thoracic Malignancies
  Journal of Thoracic Oncology 2026 DOI: 10.1016/j.jtho.2025.11.004
  +Save
• Where Do We Go With the Combination of Immune Checkpoint Inhibitors With Anti-Angiogenesis in Advanced NSCLC?
  Journal of Thoracic Oncology 2025 DOI: 10.1016/j.jtho.2025.06.031
  +Save
• Identification of KIFC3 as a Colorectal Cancer Biomarker and Its Regulatory Mechanism in the Immune Microenvironment Based on Integrated Analysis of Multi-Omics Databases
  Biomedicines 2025 DOI: 10.3390/biomedicines13040859
  +Save
• SOX8 promotes tumor growth and metastasis through FZD6-dependent Wnt/β-catenin signaling in colorectal carcinoma
  Heliyon 2023 DOI: 10.1016/j.heliyon.2023.e22586
  +Save
• Adipocyte-derived CCDC3 promotes tumorigenesis in epithelial ovarian cancer through the Wnt/ß-catenin signalling pathway
  Biochemistry and Biophysics Reports 2023 DOI: 10.1016/j.bbrep.2023.101507
  +Save
• Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer
  Journal of the National Cancer Center 2022 DOI: 10.1016/j.jncc.2022.10.002
  +Save
• The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
  Journal of Cancer Research and Clinical Oncology 2022 DOI: 10.1007/s00432-021-03752-x
  +Save
• Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma
  Journal for ImmunoTherapy of Cancer 2022 DOI: 10.1136/jitc-2021-003534
  +Save
• The Real-World Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer
  2021 DOI: 10.21203/rs.3.rs-282608/v1
  +Save